A Study of Tocilizumab in Combination With an Oral Contraceptive in Patients With Rheumatoid Arthritis
Part of paid clinical trials in Little Rock, Arkansas.
- Sponsor
- Hoffmann-La Roche
- Study ID
- NCT01044498
- Phase
- PHASE3
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 44 Years
- Healthy Volunteers
- Accepted
Interventions
- Tocilizumab — DRUGTocilizumab 8 mg/kg was administered in a single 1-hour infusion on Day 1 of Cycle 2.
- Ortho-Novum® 1/35 — DRUGEach Ortho-Novum® 1/35 tablet contained 1 mg of norethindrone and 0.035 mg of ethinyl estradiol.
Study Details
This open-label, randomized, cross-over study evaluated the effect of tocilizumab (TCZ) on the pharmacokinetics and pharmacodynamics of a common oral contraceptive (OC) in female patients with active rheumatoid arthritis (RA) and in healthy female volunteers of child bearing age. The RA patients received OC in combination with TCZ, whereas the healthy volunteers received OC only. The RA patients received OC in 3 cycles of 21 days each; TCZ 8 mg/kg was administered once as an intravenous infusion on the first day of Cycle 2. The healthy volunteers received OC for only one 21-day cycle.
Key Dates
- Start date
- Dec 31, 2009
- Status verified
- Mar 2013
- Primary completion
- Feb 29, 2012
- Completion
- Feb 29, 2012
Study Design
- Enrollment
- 46 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Tocilizumab 8 mg/kg + Ortho-Novum® 1/35 (Group 1)Patients with rheumatoid arthritis received Ortho-Novum® 1/35 daily on Days 1-21 of 3 consecutive 28-day cycles. On the first day of Cycle 2, patients received tocilizumab 8 mg/kg administered intravenously.
- Other: Ortho-Novum® 1/35 (Group 2)Healthy volunteers received Ortho-Novum® 1/35 tablets daily on Days 1-21 of one 28-day cycle.
Primary Outcome Measure
Serum Progesterone Level [ Time Frame: Day 21 of Cycles 1-3 for Group 1 and Day 21 of Cycle 1 for Group 2 ]
Locations (6)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| - | Little Rock | Arkansas | 72212 | - |
| - | Beverly Hills | California | 90211 | - |
| - | Ormond Beach | Florida | 32174 | - |
| - | Port Orange | Florida | 32127 | - |
| - | Duncansville | Pennsylvania | 16635 | - |
| - | San Antonio | Texas | 78222 | - |
Find similar trials in Little Rock, AR
Related Studies
- Physica System Total Knee Replacement Registry StudyRecruiting · Limacorporate S.p.a · Rancho Mirage, California
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- RA-PRO PRAGMATIC TRIALPHASE3 · Recruiting · University of Alabama at Birmingham · Auburn, Alabama
- Effect of Anti-inflammatory Diet in Rheumatoid ArthritisRecruiting · University of California, San Diego · La Jolla, California